Investigating the influence of lipids on Nano-structured lipid carrier formulation

RAJ, BRITO (2023) Investigating the influence of lipids on Nano-structured lipid carrier formulation. Journal of Medical pharmaceutical and allied sciences, 12 (6). pp. 6147-6154. ISSN 23207418

[thumbnail of 1704220057JMPAS_NOVEMBER_-_DECEMBER_2023.pdf] Archive
1704220057JMPAS_NOVEMBER_-_DECEMBER_2023.pdf

Download (985kB)

Abstract

Investigating the influence of lipids on Nano-structured lipid carrier formulation Investigating the influence of lipids on Nano-structured lipid carrier formulation School of Pharmacy, Dhanalakshmi Srinivasan University, Samayapuram, Trichy, Tamilnadu, India BRITO RAJ https://orcid.org/0000-0001-5987-3031

The study aimed to evaluate the effect of different lipids on the properties of nanostructured lipid carrier (NLC) formulations. The particle size, zeta potential, polydispersity index, entrapment efficiency, and drug release at 24 hours were analyzed for formulations containing various lipid matrices. Among the formulations tested, N3 (Compritol 888 ATO and Softigen) exhibited the most favourable characteristics, including the smallest particle size, highest entrapment efficiency, sustained drug release, and good stability, as indicated by a high zeta potential. Other lipids, such as Witepsol H 32 and Beeswax, also showed desirable properties. The formulations containing Dynasan 114 and Acconon-C-44 EP/NF resulted in larger particle sizes, lower entrapment efficiencies, and slower drug release. Cholesterol exhibited distinct properties, with a lower zeta potential and moderate drug release. The findings highlight the importance of lipid selection in determining the performance and functionality of NLC formulations. Compritol 888 ATO and Softigen were identified as suitable lipids for further optimization of NLC formulations. These lipids contribute to the formation of stable and uniform NLC particles, which are desirable for efficient drug delivery systems. The study provides valuable insights for formulating NLCs with optimized characteristics, facilitating the development of effective drug delivery systems. Future research can focus on optimizing other factors to enhance the performance and therapeutic effectiveness of NLC formulations.
12 26 2023 6147 6154 10.55522/jmpas.V12I6.5220 https://jmpas.com/abstract/1207

Item Type: Article
Subjects: Pharmacy Practice > Pharmaceutical Chemistry
Divisions: Pharmacy Practice
Depositing User: Mr IR Admin
Date Deposited: 16 Sep 2024 05:59
Last Modified: 16 Sep 2024 05:59
URI: https://ir.vistas.ac.in/id/eprint/6175

Actions (login required)

View Item
View Item